TALEN

TALEN1-pomca

ID

ZDB-TALEN-200609-1

Name

TALEN1-pomca

Previous Names

None

Target

pomca (1)

Target Sequence 1

5' - GTTGGGAAAATGCCCGCT - 3'

Target Sequence 2

5' - CACCAAGATGTTCTCCTCT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
ihb408	pomca
ihb409	pomca

Expression

Gene expression in Wild Types + TALEN1-pomca

No data available

Phenotype

Phenotype resulting from TALEN1-pomca

No data available

Phenotype of all Fish created by or utilizing TALEN1-pomca

Phenotype	Fish	Conditions	Figures
muscle glucose catabolic process decreased rate of occurrence, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 4 from Shi et al., 2019
head kidney cyp17a1 expression increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 6 from Shi et al., 2019
head kidney hsd17b3 expression increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 6 from Shi et al., 2019
trunk musculature ab1-rps6 labeling increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 4 from Shi et al., 2019
muscle fatty acid beta-oxidation increased occurrence, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 4 from Shi et al., 2019
whole organism increased weight, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 3, Fig. 4, Fig. 6, Table 2 from Shi et al., 2019
whole organism increased weight, abnormal	pomca^{ihb408/ihb408}	increased food availability	Fig. 3 from Shi et al., 2019
intestine lumen food increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 1 from Shi et al., 2019
hypophysis pomca expression decreased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 1 from Shi et al., 2019
exploration behavior decreased occurrence, abnormal	pomca^{ihb408/ihb408}	standard conditions	Table 2 from Shi et al., 2019
hypothalamus pomca expression decreased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 1 from Shi et al., 2019
background adaptation disrupted, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 1 from Shi et al., 2019
whole organism cortisol increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Table 2 from Shi et al., 2019
trunk musculature ab5-akt labeling increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 4 from Shi et al., 2019
whole organism increased weight, ameliorated	pomca^{ihb408/ihb408}	chemical treatment by environment: sirolimus	Fig. 4 from Shi et al., 2019
head kidney hsd3b1 expression decreased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 6 from Shi et al., 2019
interrenal gland hsd3b1 expression decreased distribution, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 2 from Shi et al., 2019
response to light stimulus decreased magnitude, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 2 from Shi et al., 2019
muscle amino acid catabolic process decreased rate of occurrence, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 4 from Shi et al., 2019
blood plasma testosterone increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Table 2 from Shi et al., 2019
whole organism increased weight, ameliorated	pomca^{ihb408/ihb408}	chemical treatment by environment: AZD-8055	Fig. 4 from Shi et al., 2019
blood plasma 3',5'-cyclic AMP increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Table 2 from Shi et al., 2019
head kidney cyp19a1a expression increased amount, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 6 from Shi et al., 2019
whole organism increased length, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 3, Table 2 from Shi et al., 2019
eating behavior increased occurrence, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 1, Table 2 from Shi et al., 2019
whole organism increased length, abnormal	pomca^{ihb408/ihb408}	increased food availability	Fig. 3 from Shi et al., 2019
aerobic respiration rate, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 2, Table 2 from Shi et al., 2019
aerobic respiration decreased rate, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 6 from Shi et al., 2019
muscle hyperplastic, abnormal	pomca^{ihb408/ihb408}	standard conditions	Fig. 4 from Shi et al., 2019
trunk musculature ab1-rps6 labeling increased amount, abnormal	pomca^{ihb409/ihb409}	standard conditions	Fig. 4 from Shi et al., 2019
hypophysis pomca expression decreased amount, abnormal	pomca^{ihb409/ihb409}	standard conditions	Fig. 1 from Shi et al., 2019
hypothalamus pomca expression decreased amount, abnormal	pomca^{ihb409/ihb409}	standard conditions	Fig. 1 from Shi et al., 2019
trunk musculature ab5-akt labeling increased amount, abnormal	pomca^{ihb409/ihb409}	standard conditions	Fig. 4 from Shi et al., 2019
interrenal gland hsd3b1 expression decreased distribution, abnormal	pomca^{ihb409/ihb409}	standard conditions	Fig. 2 from Shi et al., 2019
aerobic respiration decreased rate, abnormal	cyp17a1^{ihb144/ihb144}; pomca^{ihb408/ihb408}	standard conditions	Fig. 6 from Shi et al., 2019
whole organism lipid increased amount, ameliorated	cyp17a1^{ihb144/ihb144}; pomca^{ihb408/ihb408}	standard conditions	Fig. 6 from Shi et al., 2019

Citations